Detroit Red Wings NHL playoff game tickets are available for sale now, and CapitalCityTickets.com is providing excited Red Wings fans with discounted hockey tickets with promo code.

CapitalCityTickets.com carries NHL Hockey tickets for all Detroit Red Wings playoff games at Joe Louis Arena. They provide all levels of seating and price ranges for Detroit Red Wings fans.

The Detroit Red Wings are one of the NHL’s strongest hockey teams. The Red Wings have advanced in the 2015 NHL Playoffs.

See the Detroit Red Wings in NHL playoff action live. Buy tickets for individual playoff games or buy as a gift for the passionate Detroit Red Wings fan in your life.

CapitalCityTickets.com has seating available in all price ranges, and VIP seating when available is also an option.

CapitalCityTickets.com provides all levels of seating for Detroit Red Wings playoff games. Browse Here

Follow on Facebook at: http://www.facebook.com/CapitalTickets

CapitalCityTickets.com
Live Customer Support
Order by Phone Toll Free 7 Days a Week
(855) 514-5624

Browse the inventory of tickets for Detroit Red Wings at CapitalCityTickets.com today and save! http://www.capitalcitytickets.com/Detroit-Red-Wings-Tickets

Disclaimer: CapitalCityTickets.com is not associated with any artists, teams, venues, organizations, institutions, bands, or artists featured on their website in any way. Also, any names or titles used in this press release are solely for descriptive purposes and do not imply, indicate, or suggest any type of affiliation, partnership, or endorsement.

CapitalCityTickets.com is a reliable online marketplace serving the secondary market with tickets for all major concerts, sports, and theatre events. Online shoppers can take advantage of Promo Code “CITY5” while tickets last.

CapitalCityTickets.com | Live Customer Support | Order By Phone Toll Free | 7:00am-1:00am EST | (855) 514-5624

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/04/1430399556.jpeg

“Discount Detroit Red Wings NHL Playoff Tickets on Sale at CapitalCityTickets.com”

Media Contact
Company Name: CapitalCityTickets.com
Contact Person: Media Relations
Email: customerservice@capitalcitytickets.com
Phone: 1-855-514-5624
Country: United States
Website: http://www.capitalcitytickets.com/Detroit-Red-Wings-Tickets

Source: ABNewswire

ReleaseID: 27520

Washington Capitals NHL playoff game tickets are available for sale now, and CapitalCityTickets.com is providing excited Capitals fans with discount hockey tickets with promo code.

CapitalCityTickets.com carries NHL Hockey tickets for all Washington Capitals playoff games at the Verizon Center. They provide all levels of seating and price ranges for Capitals fans.

The Washington Capitals are one of the NHL’s strongest hockey teams. The Capitals have advanced in the 2015 NHL Playoffs.

See the Washington Capitals in NHL playoff action live. Buy tickets for individual playoff games or buy as a gift for the passionate Capitals fan in your life.

CapitalCityTickets.com has seating available in all price ranges, and VIP seating when available is also an option.

Feel free to compare CapitalCityTickets.com slashed ticket prices with other competitors.

CapitalCityTickets.com provides all levels of seating for Washington Capitals playoff games. Browse Here

Follow on Facebook at: http://www.facebook.com/CapitalTickets

CapitalCityTickets.com
Live Customer Support
Order by Phone Toll Free 7 Days a Week
(855) 514-5624

Browse the inventory of tickets for Washington Capitals at CapitalCityTickets.com today and save! http://www.capitalcitytickets.com/Washington-Capitals-Tickets

Disclaimer: CapitalCityTickets.com is not associated with any artists, teams, venues, organizations, institutions, bands, or artists featured on their website in any way. Also, any names or titles used in this press release are solely for descriptive purposes and do not imply, indicate, or suggest any type of affiliation, partnership, or endorsement.

CapitalCityTickets.com is a reliable online marketplace serving the secondary market with tickets for all major concerts, sports, and theatre events. Online shoppers can take advantage of Promo Code “CITY5” while tickets last.

CapitalCityTickets.com | Live Customer Support | Order By Phone Toll Free | 7:00am-1:00am EST | (855) 514-5624

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/04/1430399814.jpeg

Media Contact
Company Name: CapitalCityTickets.com
Contact Person: Media Relations
Email: customerservice@capitalcitytickets.com
Phone: 1-855-514-5624
Country: United States
Website: http://www.capitalcitytickets.com/Washington-Capitals-Tickets

Source: ABNewswire

ReleaseID: 27518

Washington Wizards NBA playoff game tickets are available for sale now, and LosAngelesTicketCompany.com is providing excited Wizards fans with cheap basketball tickets with promo code.

LosAngelesTicketCompany.com carries NBA basketball tickets for all Washington Wizards playoff games at the Verizon Center. They provide all levels of seating and price ranges for Wizards fans.

The Washington Wizards are one of the NBA’s strongest basketball teams and have advanced in the 2015 NBA playoffs.

See the Washington Wizards in NBA playoff action live. Buy tickets for individual playoff games or buy as a gift for the passionate Wizards fan in your life.

LosAngelesTicketCompany.com has seating available in all price ranges, and VIP seating is also an option when available.

Feel free to compare LosAngelesTicketCompany.com slashed ticket prices and promo code with all other competitors.

LosAngelesTicketCompany.com provides all levels of seating for Washington Wizards playoff games. Browse Here

Follow on Facebook at: http://www.facebook.com/LosAngelesTicketCompany

LosAngelesTicketCompany.com
Live Customer Support
Order by Phone Toll Free 7 Days a Week
(855) 514-5624

Browse the inventory of tickets for Washington Wizards at LosAngelesTicketCompany.com today and save! http://www.losangelesticketcompany.com/Washington-Wizards-Tickets

Disclaimer: LosAngelesTicketCompany.com is not associated with any artists, teams, venues, organizations, institutions, bands, or artists featured on their website in any way. Also, any names or titles used in this press release are solely for descriptive purposes and do not imply, indicate, or suggest any type of affiliation, partnership, or endorsement.

LosAngelesTicketCompany.com is a reliable online marketplace serving the secondary market with tickets for all major concerts, sports, and theatre events. Online shoppers can take advantage of Promo Code “VIP10” while tickets last.

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/04/1430400081.jpeg

“Discount Washington Wizards Playoff Tickets on Sale at LosAngelesTicketCompany.com”

Media Contact
Company Name: LosAngelesTicketCompany.com
Contact Person: Media Relations
Email: losangelesticketcompany@gmail.com
Phone: 1-855-514-5624
Country: United States
Website: http://www.losangelesticketcompany.com/Washington-Wizards-Tickets

Source: ABNewswire

ReleaseID: 27516

30 April, 2015 – USA – What separates Genius from Average in today’s top content marketing strategies? By Genius I mean a company or person who uses resources (social media, video and data) in connection with traditional marketing tactics. By Average, I mean someone who is driving normal results.

What might amazing content strategists know that you don’t? More importantly: What can we learn and gain from them in order to skill transfer like results into your own company?

Netjumps Intl. and Sheldon Michael’s team wanted to form that study. We grabbed our Monster Energy Drinks and our MacBooks and hit the road to know-where when we released our fifth annual study, “B2B Content Digital Marketing: 2015 Growth and awareness conference—North America,” Focusing on more than 250 companies in 109 countries. Here is what we stumbled upon.

Genius content strategists have a specific strategy and militantly stay their course. A meager 35% of content creationists actually have a documented strategy according to our study. Sixty percent of those who have a documented strategy rate themselves as having scalable models, compared to those who have no strategy that is documented.

Lesson Learned: Clearly define a content strategy for your team, document it and use it as a reference. Start by using it as a questionnaire doc about your company: Who’s your audience? What value can you provide? What delivery options do you have? What management positions do you have in place? How do you record results and how do you refine those results to scale?

Genius content strategists have a dedicated team. We found that less than 50% have a dedicated team full time. However the 70% that were successful in this space had a full time team of 5 or more employees.

Lesson Learned: Empower a full time content marketing team (If your a small firm one dedicated employee will suit just fine) that’s main priority and central focus is strictly wired around your content marketing program.

Genius content strategists use a plethora of skill sets and social media products.The most successful firms don’t rely on just one or two techniques to reach and engage their audiences. On the contrary effective ones use an average of 20 or more skills and tactics and at least 7 social platforms.

Tactics for Business to business content strategies include but are not limited to live events, webinars or visual casts, videos, blogs, white papers, case studies or e-books, research reports, e-newsletters and landing pages and microsites. We found the successful social syndications to be (in descending order) LinkedIn, Twitter, Facebook, YouTube and SlideShare.

Lesson Learned: Generate content that has variety in its broadest sense—Try to stray away from blog posts and or case studies that have been used over and over again. Use a diverse social media plan so that you cater to all end users.

Genius strategists focus on fresh ideas. The most effective digital marketers publish fresh and new content daily, or at least several times per week.

Lesson learned: Use and master the use of an editorial calendar. Have a master plan. Knowing who, what, when, and why 6 months in advance does not hurt it helps.

Genius content strategists spend more money. This puts the ah in Ball-ah: More money= more content more content=marketing. The most effective marketers invest 40% of their budgets into content strategies.

Lesson learned: Find more money get more gains. The principle of investment ask Donald Trump.

If you want more information just visit the website http://netjumps.com

Media Contact
Company Name: Netjumps International
Contact Person: Sheldon Michael
Email: SheldonM@netjumps.com
Phone: (888) 394-3332
Address:23905 Clinton Keith Rd, 114-145
City: Wildomar
State: CA
Country: United States
Website: http://netjumps.com

Source: ABNewswire

ReleaseID: 27515

April 30, 2015 – Irvine, California – Vivid Smoke is focused on helping people find an alternative to smoking by offering a huge selection of e-cigarettes and vaping products for all user types. Whether you’re a beginner or an advanced user, Vivid Smoke’s online catalog is easy to navigate to get what you want, when you want it and at the price you need it. In the last few years, vaping has established itself as the most effective and safest alternatives to smoking, with no unpleasant smells or carcinogens.

The latest addition to Vivid Smoke’s catalog is the Epoch D1 RTA, which features an exclusive top-filling design for convenient juice filling of its 2.5ml capacity glass tank. Measuring 22mm in diameter, the Epoch D1 RTA is the perfect fit for the vast majority of mods in today’s market. Inside, it houses a T-style center post with two negative posts that allows for dual-coil builds. The RTA also has adjustable airflow control with two offset air holes and boasts a tool-less design for ease of use on a daily basis. To fill the Epoch D1 RTA with juice, you simply need to close the juice control on the deck, pull off the top cap and fill the juice. The Epoch D1 RTA comes complete with a drip cap, a bag of spare o-rings and a screwdriver to adjust the connectivity pin.

Even if the Epoch D1 RTA doesn’t strike your attention, Vivid Smoke offers a plethora of products ranging from affordable mods to high-end atomizers that you can customize to your heart’s content. There are also combo kits and beginner kits for the inexperienced user looking to get into vaping as an alternative to smoking. If you’re into personalizing your vaping experience, Vivid Smoke also specializes in color-coordinated combo kits, whether it’s black, white, rainbow or blue.

Now if you’ve already been vaping for quite some time now and need a new source for your consumables, Vivid Smoke stocks Kanthal wire, 100-percent organic cotton, various juices from popular brands including Cuttwood, Cosmic Fog, The Milkman and Cereal Killa by 9 South Vapes and every atomizer coil imaginable. Or maybe you just need a drip tip to complete your setup – Vivid Smoke has you covered there too! And don’t forget the selection of batteries, chargers and volt meters that are available to make sure you’re vaping through the day safely.

Founded in 2009, Vivid Smoke specializes in e-cigarettes and vaping products, providing a healthier alternative to traditional cigarettes.

For more information just visit the website http://vividsmoke.com

Media Contact
Company Name: Vivid Smoke
Contact Person: Debbie
Email: media@vividsmoke.com
Phone: 714-868-6154
Address:17595 Harvard Ave
City: Irvine
State: CA
Country: United States
Website: http://vividsmoke.com

Source: ABNewswire

ReleaseID: 27514

According to new report published by Grand View Research, increasing internal and external security concern globally is expected to drive the armored vehicle market during the forecast period.

The armored vehicle market is expected to witness high growth over the next six years owing to its defense and commercial uses. These vehicles enhance the capability of ground forces; therefore, they are expected to be an integral part of military operations over the forecast period. Increasing internal and external security concern globally is expected to drive the armored vehicle market. Rise in defense spending and commercial security consciousness is expected to be favorable for the global market. Additionally, increasing technological advancements and modernization is also expected to fuel armored vehicle market growth. Political and social concerns may act as critical factors effecting market dynamics over the forecast period. High investment and environmental threats may hinder market growth.

Full research report on Global Armored Vehicle Market with detailed figures and charts available at:
http://www.grandviewresearch.com/industry-analysis/armored-vehicle-market

The armored vehicle market can be segmented on the basis of product and application. Product segments includes Mine Resistant Ambush Protected Vehicles (MRAP), amphibious armored vehicles, main light protected vehicles, unmanned ground vehicles and battle tanks. Further, armored vehicles can be used for defense and commercial applications. Defense is expected to contribute significantly to the market and grow at a considerable rate over the forecast period.

The North America market has grown at considerable rate over the past few years owing to its efforts to counter terrorism. Asia Pacific is expected to be the most lucrative market over the forecast period due to increase in defense expenditure from China and India. Additionally, territorial disputes between nations in the region are also expected to contribute to the armored vehicle market.

Get more information on Global Armored Vehicle Market or request for TOC of this research report at:
http://www.grandviewresearch.com/industry-analysis/armored-vehicle-market/request-toc

Few key market players include Elbit Systems, BAE Systems, Navistar International Corporation, Oshkosh, General Dynamics Corporation, Lockheed Martin, Rheinmetall, Krauss-Maffei Wegmann GmbH and Ivecs. In December 2014, Estonia signed a deal worth USD 120 million with the Netherlands to buy 44 infantry combat vehicles.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/automotive-and-transportation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information, visit: http://www.grandviewresearch.com/

Blog: http://www.mediafound.org/

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/04/1430385899.jpeg

“Grand View Research, Inc. – Market Research And Consulting.”

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James
Email: haakon@grandviewresearch.com
Phone: 1-415-349-0058
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: http://www.grandviewresearch.com/industry-analysis/armored-vehicle-market

Source: ABNewswire

ReleaseID: 27511

According to new report published by Grand View Research, global prevalence of chronic obstructive pulmonary disorder (COPD) will be the major driver for oxygen therapy market during the forecast period.

Global prevalence of chronic obstructive pulmonary disorder (COPD) is the major driver for oxygen therapy market. Oxygen therapy is one of the leading treatments for the patients suffering from various conditions resulting from oxygen deficiency including chronic obstructive pulmonary disorder. It is not restricted to the elderly but people above the age of 65 are at a greater risk to develop the disease. In addition, factors other than age also have immense role in the requirement of oxygen therapy such as environmental exposure, a severe asthma attack, cystic fibrosis, sleep apnea, late stage heart failure and smoking.

Full research report on Global Oxygen Therapy Market with detailed figures and charts available at:
http://www.grandviewresearch.com/industry-analysis/oxygen-therapy-market

Nasal cannula, transtracheal oxygen therapy and face mask are the major products of oxygen therapy market. Nasal cannula is expected to witness rapid growth during the forecast period due to the increasing cases of medical procedures and the requirement of oxygen therapy during the time of surgeries. Geographically, North America occupied the largest share of the oxygen therapy market, owing to the fact that COPD is one of the leading causes of deaths in the United States. Geriatric population in the U.S is growing at a faster rate than the overall population therefore increasing the number of cases of patients suffering from COPD. The Asia Pacific market is expected to witness a significant increase in demand for oxygen therapy during the forecast period owing to the increasing incidences of pulmonary disorder and heart failure.

Get more information on Global Oxygen Therapy Market or request for TOC of this research report at:
http://www.grandviewresearch.com/industry-analysis/oxygen-therapy-market/request-toc

The key companies operating in the market for obesity surgical devices are AstraZeneca, CareFusion, Inc., Fisher & Paykel Healthcare Limited, Chart Industries Inc., GE Healthcare, Medical Systems, 3M, Merck & Company, Inc., Merck & Company, DeVilbiss Healthcare, and Philips/Respironics. In November 2014, Innova labs introduced portable oxygen concentrators with Activox 4L which reduces the uncomfortable side effects such as nose bleeding and dry nose associated with the traditional delivery method.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/medical-devices

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information, visit: http://www.grandviewresearch.com/

Blog: http://www.altubina.com/

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/04/1430386783.jpeg

“Grand View Research, Inc. – Market Research And Consulting”

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James
Email: haakon@grandviewresearch.com
Phone: 1-415-349-0058
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States
Website: http://www.grandviewresearch.com/industry-analysis/oxygen-therapy-market

Source: ABNewswire

ReleaseID: 27509

New Market Research Reports Title “Global Wind Turbine Casting Market Analysis Report to 2015: Radiant Insights, Inc” Has Been Added to RadiantInsights.com Report Database.

For overview analysis, the report introduces Wind Turbine Casting basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc.

Browse Full Report With TOC at:
http://www.radiantinsights.com/research/global-wind-turbine-casting-industry-2015-market-research-report

For international and China market analysis, the report analyzes Wind Turbine Casting markets in China and other countries or regions (such as US, Europe, Japan, etc) by presenting research on global products of different types and applications, developments and trends of market, technology, competitive landscape, and leading suppliers’ and countries’ 2009-2014 capacity, production, cost, price, profit, production value, and gross margin. For leading suppliers, related information is listed as products, customers, application, capacity, market position, and company Contact information, etc. 2015-2020 forecast on capacity, production, cost, price, profit, production value, and gross margin for these markets are also included.

For technical data and manufacturing plants analysis, the report analyzes Wind Turbine Casting leading suppliers on capacity, commercial production date, manufacturing plants distribution, R&D status, technology sources, and raw materials sources.

For industry chain analysis, the report covers Wind Turbine Casting upstream raw materials, equipment, downstream client survey, marketing channels, industry development trend and proposals, which more specifically include valuable information on Wind Turbine Casting key applications and consumption, key regions and consumption, key global distributors , major raw materials suppliers and contact information, major manufacturing equipment suppliers and contact information, major suppliers and contact Information, key consumers and contact information, and supply chain relationship analysis.

See More Reports of This Category by Radiant Insights at:
http://www.radiantinsights.com/catalog/machines-and-parts

This report also presents Wind Turbine Casting product specification, manufacturing process, and product cost structure etc. Production is separated by regions, technology and applications. In the end, the report includes Wind Turbine Casting new project SWOT analysis, investment feasibility analysis, investment return analysis, and development trend analysis.

In conclusion, it is a deep research report on global Wind Turbine Casting industry. Here, we express our thanks for the support and assistance from Wind Turbine Casting industry chain related technical experts and marketing engineers during research team’s survey and interviews

Latest Report by Radiant Insights

Tachometer Generators Market Analysis Report 2015:
http://www.radiantinsights.com/research/global-tachometer-generators-industry-2015-market-research-report

For international and China market analysis, the report analyzes Tachometer Generators markets in China and other countries or regions (such as US, Europe, Japan, etc) by presenting research on global products of different types and applications, developments and trends of market, technology, competitive landscape, and leading suppliers’ and countries’ 2009-2014 capacity, production, cost, price, profit, production value, and gross margin. For leading suppliers, related information is listed as products, customers, application, capacity, market position, and company Contact information, etc. 2015-2020 forecast on capacity, production, cost, price, profit, production value, and gross margin for these markets are also included.

CNC Spindle Market Research Report to 2015:
http://www.radiantinsights.com/research/global-cnc-spindle-industry-2015-market-research-report

For technical data and manufacturing plants analysis, the report analyzes CNC Spindle leading suppliers on capacity, commercial production date, manufacturing plants distribution, R&D status, technology sources, and raw materials sources.

For industry chain analysis, the report covers CNC Spindle upstream raw materials, equipment, downstream client survey, marketing channels, industry development trend and proposals, which more specifically include valuable information on CNC Spindle key applications and consumption, key regions and consumption, key global distributors , major raw materials suppliers and contact information, major manufacturing equipment suppliers and contact information, major suppliers and contact Information, key consumers and contact information, and supply chain relationship analysis.

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For More Information, Visit: http://www.radiantinsights.com/

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/04/1430387651.jpeg

“Radiant Insights Logo”

Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Email: sales@radiantinsights.com
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: Califonia
Country: United States
Website: http://www.radiantinsights.com/research/global-wind-turbine-casting-industry-2015-market-research-report

Source: ABNewswire

ReleaseID: 27507

RadiantInsights.com has announced the addition of “Global Acute Myeloid Leukemia Therapeutics Market to 2020: Radiant Insights, Inc” Market Research Report to their Database.

GBI Research, has released its latest pharma report, “Acute Myeloid Leukemia Therapeutics Market to 2020 – Novel Therapies to Offer Clinical Benefit in Small Patient Cohorts”

Treatment and prognosis in AML is strongly influenced by a patient’s age, and their cytogenetic profile. In the majority of cases these two prognostic influences are linked, with a higher frequency of unfavorable cytogenetic abnormalities observed in the elderly. Survival in this cohort of elderly patients is very poor, with a five year overall survival of 3-8% (Luger, 2010). Despite a relatively advanced understanding of genetic abnormalities associated with AML, the introduction of targeted therapies is lagging in this indication in comparison to other cancers such as breast and lung cancer, with no approved targeted therapies. Such slow development may be a reflection of AMLs status as an orphan indication.

Browse Full Report With TOC at:
http://www.radiantinsights.com/research/acute-myeloid-leukemia-therapeutics-market-to-2020-novel-therapies-to-offer-clinical-benefit-in-small-patient-cohorts

Intensive treatment in eligible patients (younger patients, and approximately 50% of diagnosed elderly patients) is typically the combination of the two chemotherapeutic agents cytarabine and daunorubicin, both of which were approved in the 1960s. In patients ineligible for intensive first-line chemotherapy, options are very poor, with the more recently approved Vidaza and Dacogen as the treatment options, which both offer unsatisfactory survival. Across all newly diagnosed patients that obtain complete remission, a stem cell transplant offers the highest chance of long-term survival. However, this procedure is risky, with a higher rate of treatment related mortality in the absence of better techniques to reduce the risk of graft-versus-host disease.

The majority of patients experience disease relapse, which is almost always fatal. Treatment options in these patients typically involve the off-label use of chemotherapeutic agents, whether in combination or as monotherapies.

There are clear gaps in the market for therapies to meet several unmet needs by increasing the initial length of remission; improving treatment options for newly-diagnosed patients, ineligible for relapsed disease treatments; improving the success of and reducing the side effects of stem cell transplantation; and improving survival, safety and quality of life in patients with relapsed disease. The current developmental pipeline addresses these gaps in the market, along with the significant lack of targeted therapies. Five of the eight pipeline products are under development as non-intensive therapies for the elderly, and six of the eight products are being investigated in relapsed disease.

Results so far have been mixed, with several drugs offering no overwhelming clinical benefit in Phase I and II clinical trials. Some drugs have demonstrated encouraging results – namely CPX-351, quizartinib, StemEx, treosulfan and midostaurin. All of these drugs are forecast to be approved within the forecast period, a result of clinical trial data that suggest these drugs can offer improved survival in comparison to the currently marketed products. It is important to note however, that these improvements and the subsequent approval of these products is restricted to small patient cohorts – including patients with secondary AML, those with internal tandem repeats in Fms-like tyrosine kinase, and patients eligible for a stem cell transplant, but for whom a matched donor cannot be found. This fragmentation in the treatment algorithm is a reflection of the heterogeneity of AML, with continued fractionation likely to be essential for further effective treatments to be developed. This is reflected in the current developmental pipeline, with drugs targeting a high variety of molecule types and molecular targets currently under investigation in this disease.

The small patient cohorts the pipeline drugs are expected to be approved in will result in each having a minimal effect on any growth in market revenues over the forecast period. They will nevertheless stimulate market growth. An increase in prevalence and treatment populations, driven by aging populations across each territory will also have a positive effect on market revenues. However, as an orphan indication, the effect of population growth is also expected to have a minor effect. As a result, the global market revenues are forecast to rise at a limited CAGR of 4.8% from $632.4m in 2013 to $878.2m in 2020.

See More Reports of This Category by Radiant Insights at:
http://www.radiantinsights.com/catalog/pharmaceuticals-and-healthcare

Scope

The report analyzes treatment usage patterns, marketed and pipeline drugs, and market forecasts across indications for AML.The report covers and includes —

• A brief introduction to AML, including the disease’s pathogenesis, risk factors and diagnosis
• An in-depth analysis of the drug combinations used in the treatment of AML, including analyses of their safety, efficacy, and place in the disease treatment algorithm. This includes a heat map comparing the drug combinations in terms of safety and efficacy
• A comprehensive review of the pipeline for AML therapies, including individual analysis of a number of late-stage pipeline drugs that have the potential to enter the market during the forecast period. The pipeline is analyzed on the basis of Phase distribution, molecule types and molecular targets, as well as administration routes
• An additional in-depth analysis of pipeline drug clinical trials by phase, trial size, trial duration and program failure rate analyses for each molecule type and molecular target
• A multi-scenario forecast data for the market to 2020, taking into account how it will be affected by the introduction of new drugs, the expiry of key patents on current drugs and the changes in disease epidemiology across the key developed markets including the US, Canada, Japan, Germany, the UK, France, Italy and Spain
• A discussion of the drivers and barriers for market growth
• An in-depth analysis of licensing and co-development deals involving drugs indicated in AML, including an in-depth outline of the key deals

Get more information on Global Acute Myeloid Leukemia Therapeutics Market for TOC of this research report at:
http://www.radiantinsights.com/research/acute-myeloid-leukemia-therapeutics-market-to-2020-novel-therapies-to-offer-clinical-benefit-in-small-patient-cohorts

Reasons to buy

The report will assist business development and enable marketing executives to strategize their product launches, by allowing them to —

• Understand the efficacy and safety of the current monotherapies and drug combinations used in the treatment of AML, with in-depth analysis of the disease treatment algorithm
• Understand the key signaling pathways and molecular targets currently under investigation in drug development for AML
• Understand the vast Scope of the pipeline, including which molecule types and molecular targets are most prominent
• Observe the trends in clinical trial duration and size by clinical phase and molecule type, and use the clinical trial failure rate analysis to assess the risk profiles of current and/or future developmental programs for AML cancer therapeutics
• Assess the potential clinical and commercial impact of current late-stage pipeline molecules in the AML therapeutics market
• Assess the location of involved companies, and the value of both licensing and co-development deals involving drugs under investigation for the treatment of AML

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For More Information, Visit: http://www.radiantinsights.com/

Logo: http://www.abnewswire.com/pressreleases/wp-content/uploads/2015/04/1430389257.jpeg

“Radiant Insights Logo”

Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist – USA
Email: sales@radiantinsights.com
Phone: (415) 349-0054, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: Califonia
Country: United States
Website: http://www.radiantinsights.com/research/acute-myeloid-leukemia-therapeutics-market-to-2020-novel-therapies-to-offer-clinical-benefit-in-small-patient-cohorts

Source: ABNewswire

ReleaseID: 27505